Outlook Therapeutics, Inc.

OTLK

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001649989

SEC filings (opens in a new tab)

In the last 90 days, Outlook Therapeutics, Inc. insiders filed 4 open-market purchases and 0 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $32.2M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Outlook Therapeutics, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of OTLK: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Q2 2023	Change
Holders	82	87	+5
Shares	27.3M	29.4M	+2.06M (+7.5%)
Value	$29.8M	$51.1M	+$21.3M (+71.7%)

New holders (12)

Institutions that held Outlook Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to OTLK in Q2 2023
Institution	Shares	Value	% of portfolio
Manufacturers Life Insurance Company, The	65,368	$113.7K	0.00%
Scotia Capital Inc.	64,976	$113.1K	0.00%
Verition Fund Management LLC	53,600	$93.3K	0.00%
Citigroup Inc	46,195	$80.4K	0.00%
State Board of Administration of Florida Retirement System	44,030	$76.6K	0.00%
Main Street Financial Solutions, LLC	25,000	$43.5K	0.01%
Jane Street Group, LLC	23,639	$41.1K	0.00%
Stratos Wealth Advisors, LLC	17,000	$29.6K	0.00%
Exencial Wealth Advisors, LLC	15,221	$26.5K	0.00%
Two Sigma Securities, LLC	12,497	$21.7K	0.00%
Prudential Financial Inc	10,270	$17.9K	0.00%
Signaturefd, LLC	65	$113	0.00%

Sold out (7)

Institutions that held Outlook Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of OTLK in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Vista Finance, LLC	217,640	$237.2K
Gsa Capital Partners LLP	97,839	$107.0K
Citadel Advisors LLC	90,657	$98.8K
SG Americas Securities, LLC	61,941	$68.0K
Fisher Asset Management, LLC	12,476	$13.6K
CNB Bank	10,000	$10.9K
Psagot Value Holdings Ltd. / (Israel)	2,817	$3.00K